ClinicalThought

Share

Program Content

Activities

  • T-DXd: ILD Management
    How I Manage Interstitial Lung Disease Associated With Trastuzumab Deruxtecan in My Patients With HER2-Positive MBC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 10, 2020

    Expires: September 09, 2021

  • FAQ: HER2+ MBC
    Frequently Asked Questions in HER2-Positive Metastatic Breast Cancer Care
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 11, 2020

    Expires: September 10, 2021

Faculty

cover img faculity

Adam M. Brufsky, MD, PhD

Associate Professor
Department of Medicine, Division of Hematology/Oncology
University of Pittsburgh
Pittsburgh, Pennsylvania

cover img faculity

Cristina Saura, MD, PhD

Medicine and Surgery/Medical Oncology
Universidad Universitat Autònoma Barcelona and Vall d’Hebron Institute of Oncology (VHIO)
Head, Breast Cancer Program
Medical Oncology
Vall d’Hebrón University Hospital
Barcelona, Spain

Provided by

ProCE Banner

Supporters

Daiichi Sankyo, Inc.